Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The primary aim is to test whether preoperative asepsis with 5% nasal povidone iodine versus no preoperative asepsis with 5% nasal povidone iodine reduces proximal and distal SARS-CoV-2 transmission in operating rooms among patients who are acutely infected with SARS-CoV-2. The secondary aim is to test viral infectivity.
Epistemonikos ID: 5f8efe1536f98532677e1529be8518f5afd45cff
First added on: Feb 28, 2023